{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:07:05Z","timestamp":1764022025401,"version":"3.45.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10147-025-02908-w","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:55:48Z","timestamp":1761731748000},"page":"2576-2586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Site-specific prevalence of the NFE2L2 mutation in esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"30","author":[{"given":"Akihiko","family":"Chida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-8015","authenticated-orcid":false,"given":"Hideyuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichiro","family":"So","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tsugaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"6","key":"2908_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"7636","key":"2908_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network (2017) Integrated genomic characterization of oesophageal carcinoma. Nature 541(7636):169\u2013175. https:\/\/doi.org\/10.1038\/nature20805","journal-title":"Nature"},{"issue":"12","key":"2908_CR3","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.ccell.2023.11.003","volume":"41","author":"J Chang","year":"2023","unstructured":"Chang J, Zhao X, Wang Y et al (2023) Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development. Cancer Cell 41(12):2038-2050.e2035. https:\/\/doi.org\/10.1016\/j.ccell.2023.11.003","journal-title":"Cancer Cell"},{"issue":"1","key":"2908_CR4","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/s41467-023-37440-w","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Jiang D, Zhang Q et al (2023) Integrative proteogenomic characterization of early esophageal cancer. Nat Commun 14(1):1666. https:\/\/doi.org\/10.1038\/s41467-023-37440-w","journal-title":"Nat Commun"},{"issue":"2","key":"2908_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","volume":"3","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Tomasello G, Borgonovo K et al (2017) Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol 3(2):211\u2013219. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4227","journal-title":"JAMA Oncol"},{"issue":"1","key":"2908_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-020-00785-y","volume":"18","author":"M Watanabe","year":"2021","unstructured":"Watanabe M, Tachimori Y, Oyama T et al (2021) Comprehensive registry of esophageal cancer in Japan, 2013. Esophagus 18(1):1\u201324. https:\/\/doi.org\/10.1007\/s10388-020-00785-y","journal-title":"Esophagus"},{"issue":"3","key":"2908_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H et al (2023) Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: Part 1. Esophagus 20(3):343\u2013372. https:\/\/doi.org\/10.1007\/s10388-023-00993-2","journal-title":"Esophagus"},{"issue":"4","key":"2908_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.anl.2017.02.004","volume":"44","author":"KI Nibu","year":"2017","unstructured":"Nibu KI, Hayashi R, Asakage T et al (2017) Japanese clinical practice guideline for head and neck cancer. Auris Nasus Larynx 44(4):375\u2013380. https:\/\/doi.org\/10.1016\/j.anl.2017.02.004","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"2908_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/j.gastro.2019.04.017","volume":"157","author":"K Minashi","year":"2019","unstructured":"Minashi K, Nihei K, Mizusawa J et al (2019) Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology 157(2):382-390.e383. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.017","journal-title":"Gastroenterology"},{"issue":"8","key":"2908_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2017.36","volume":"8","author":"K Hamada","year":"2017","unstructured":"Hamada K, Ishihara R, Yamasaki Y et al (2017) Efficacy and safety of endoscopic resection followed by chemoradiotherapy for superficial esophageal squamous cell carcinoma: a retrospective study. Clin Transl Gastroenterol 8(8):e110. https:\/\/doi.org\/10.1038\/ctg.2017.36","journal-title":"Clin Transl Gastroenterol"},{"issue":"9","key":"2908_CR11","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdx279","volume":"28","author":"G Murphy","year":"2017","unstructured":"Murphy G, McCormack V, Abedi-Ardekani B et al (2017) International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol 28(9):2086\u20132093. https:\/\/doi.org\/10.1093\/annonc\/mdx279","journal-title":"Ann Oncol"},{"issue":"4","key":"2908_CR12","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1002\/onco.13639","volume":"26","author":"M Takeda","year":"2021","unstructured":"Takeda M, Takahama T, Sakai K et al (2021) Clinical application of the foundationone CDx assay to therapeutic decision-making for patients with advanced solid tumors. Oncologist 26(4):e588\u2013e596. https:\/\/doi.org\/10.1002\/onco.13639","journal-title":"Oncologist"},{"issue":"4","key":"2908_CR13","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/cas.13969","volume":"110","author":"K Sunami","year":"2019","unstructured":"Sunami K, Ichikawa H, Kubo T et al (2019) Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci 110(4):1480\u20131490. https:\/\/doi.org\/10.1111\/cas.13969","journal-title":"Cancer Sci"},{"issue":"10","key":"2908_CR14","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1111\/cas.14608","volume":"111","author":"H Hayashi","year":"2020","unstructured":"Hayashi H, Tanishima S, Fujii K et al (2020) Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system. Cancer Sci 111(10):3926\u20133937. https:\/\/doi.org\/10.1111\/cas.14608","journal-title":"Cancer Sci"},{"issue":"9","key":"2908_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25317","volume":"4","author":"R Ishihara","year":"2021","unstructured":"Ishihara R, Mizusawa J, Kushima R et al (2021) Assessment of the diagnostic performance of endoscopic ultrasonography after conventional endoscopy for the evaluation of esophageal squamous cell carcinoma invasion depth. JAMA Netw Open 4(9):e2125317. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.25317","journal-title":"JAMA Netw Open"},{"issue":"7739","key":"2908_CR16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T et al (2019) Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565(7739):312\u2013317. https:\/\/doi.org\/10.1038\/s41586-018-0811-x","journal-title":"Nature"},{"issue":"5","key":"2908_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ng.2591","volume":"45","author":"AM Dulak","year":"2013","unstructured":"Dulak AM, Stojanov P, Peng S et al (2013) Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 45(5):478\u2013486. https:\/\/doi.org\/10.1038\/ng.2591","journal-title":"Nat Genet"},{"issue":"4","key":"2908_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.2653","volume":"220","author":"YR Kim","year":"2010","unstructured":"Kim YR, Oh JE, Kim MS et al (2010) Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 220(4):446\u2013451. https:\/\/doi.org\/10.1002\/path.2653","journal-title":"J Pathol"},{"issue":"10","key":"2908_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","volume":"30","author":"Y Cui","year":"2020","unstructured":"Cui Y, Chen H, Xi R et al (2020) Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res 30(10):902\u2013913. https:\/\/doi.org\/10.1038\/s41422-020-0333-6","journal-title":"Cell Res"},{"issue":"10","key":"2908_CR20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ng.3076","volume":"46","author":"YB Gao","year":"2014","unstructured":"Gao YB, Chen ZL, Li JG et al (2014) Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 46(10):1097\u20131102. https:\/\/doi.org\/10.1038\/ng.3076","journal-title":"Nat Genet"},{"issue":"7","key":"2908_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41379-022-01010-0","volume":"35","author":"X Jiang","year":"2022","unstructured":"Jiang X, Zhou X, Yu X et al (2022) High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients. Mod Pathol 35(7):929\u2013937. https:\/\/doi.org\/10.1038\/s41379-022-01010-0","journal-title":"Mod Pathol"},{"issue":"6220","key":"2908_CR22","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM et al (2015) Proteomics tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"issue":"3","key":"2908_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","volume":"98","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Kensler TW, Motohashi H (2018) The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev 98(3):1169\u20131203. https:\/\/doi.org\/10.1152\/physrev.00023.2017","journal-title":"Physiol Rev"},{"issue":"1","key":"2908_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34(1):21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022","journal-title":"Cancer Cell"},{"issue":"1","key":"2908_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1158\/1078-0432.Ccr-19-1237","volume":"26","author":"Y Jeong","year":"2020","unstructured":"Jeong Y, Hellyer JA, Stehr H et al (2020) Role of KEAP1\/NFE2L2 mutations in the chemotherapeutic response of patients with non-small cell lung cancer. Clin Cancer Res 26(1):274\u2013281. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-1237","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2908_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/nyas.13681","volume":"1434","author":"S Ma","year":"2018","unstructured":"Ma S, Paiboonrungruan C, Yan T et al (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434(1):164\u2013172. https:\/\/doi.org\/10.1111\/nyas.13681","journal-title":"Ann N Y Acad Sci"},{"key":"2908_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147194","volume":"858","author":"X Chen","year":"2023","unstructured":"Chen X, Yu L, Zhou J et al (2023) Inhibition of p62 and\/or NFE2L2 induced autophagy impaires esophageal squamous cell cancer metastasis by reversing EMT. Gene 858:147194. https:\/\/doi.org\/10.1016\/j.gene.2023.147194","journal-title":"Gene"},{"issue":"4","key":"2908_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jtho.2022.09.225","volume":"18","author":"PK Paik","year":"2023","unstructured":"Paik PK, Fan PD, Qeriqi B et al (2023) Targeting NFE2L2\/KEAP1 mutations in advanced NSCLC with the TORC1\/2 inhibitor TAK-228. J Thorac Oncol 18(4):516\u2013526. https:\/\/doi.org\/10.1016\/j.jtho.2022.09.225","journal-title":"J Thorac Oncol"},{"key":"2908_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2016.12.041","volume":"103","author":"K Tsuchida","year":"2017","unstructured":"Tsuchida K, Tsujita T, Hayashi M et al (2017) Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation. Free Radic Biol Med 103:236\u2013247. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.12.041","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2908_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2014.04.039","volume":"447","author":"S Chian","year":"2014","unstructured":"Chian S, Thapa R, Chi Z et al (2014) Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo. Biochem Biophys Res Commun 447(4):602\u2013608. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.039","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2908_CR31","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.7150\/ijbs.82401","volume":"19","author":"J Zhang","year":"2023","unstructured":"Zhang J, Xu HX, Zhu JQ et al (2023) Natural Nrf2 inhibitors: a review of their potential for cancer treatment. Int J Biol Sci 19(10):3029\u20133041. https:\/\/doi.org\/10.7150\/ijbs.82401","journal-title":"Int J Biol Sci"},{"issue":"47","key":"2908_CR32","doi-asserted-by":"publisher","first-page":"82085","DOI":"10.18632\/oncotarget.18294","volume":"8","author":"AM Gao","year":"2017","unstructured":"Gao AM, Zhang XY, Ke ZP (2017) Apigenin sensitizes BEL-7402\/ADM cells to doxorubicin through inhibiting miR-101\/Nrf2 pathway. Oncotarget 8(47):82085\u201382091. https:\/\/doi.org\/10.18632\/oncotarget.18294","journal-title":"Oncotarget"},{"issue":"8","key":"2908_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"MB Sporn","year":"2012","unstructured":"Sporn MB, Liby KT (2012) NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 12(8):564\u2013571. https:\/\/doi.org\/10.1038\/nrc3278","journal-title":"Nat Rev Cancer"},{"key":"2908_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12103023","author":"JM DeBlasi","year":"2020","unstructured":"DeBlasi JM, DeNicola GM (2020) Dissecting the crosstalk between NRF2 signaling and metabolic processes in cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12103023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2908_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1021\/tx000118t","volume":"13","author":"M Wang","year":"2000","unstructured":"Wang M, McIntee EJ, Cheng G et al (2000) Identification of DNA adducts of acetaldehyde. Chem Res Toxicol 13(11):1149\u20131157. https:\/\/doi.org\/10.1021\/tx000118t","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"2908_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0921-8777(95)00006-6","volume":"337","author":"NP Singh","year":"1995","unstructured":"Singh NP, Khan A (1995) Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutat Res 337(1):9\u201317. https:\/\/doi.org\/10.1016\/0921-8777(95)00006-6","journal-title":"Mutat Res"},{"issue":"11","key":"2908_CR37","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/carcin\/22.11.1825","volume":"22","author":"P Noori","year":"2001","unstructured":"Noori P, Hou SM (2001) Mutational spectrum induced by acetaldehyde in the HPRT gene of human T lymphocytes resembles that in the p53 gene of esophageal cancers. Carcinogenesis 22(11):1825\u20131830. https:\/\/doi.org\/10.1093\/carcin\/22.11.1825","journal-title":"Carcinogenesis"},{"issue":"3","key":"2908_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0167-8817(85)90072-0","volume":"146","author":"B Lambert","year":"1985","unstructured":"Lambert B, Chen Y, He SM et al (1985) DNA cross-links in human leucocytes treated with vinyl acetate and acetaldehyde in vitro. Mutat Res 146(3):301\u2013303. https:\/\/doi.org\/10.1016\/0167-8817(85)90072-0","journal-title":"Mutat Res"},{"issue":"16","key":"2908_CR39","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1042\/bcj20200452","volume":"477","author":"JO Odera","year":"2020","unstructured":"Odera JO, Xiong Z, Huang C et al (2020) Nrf2\/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma. Biochem J 477(16):3075\u20133089. https:\/\/doi.org\/10.1042\/bcj20200452","journal-title":"Biochem J"},{"key":"2908_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fcell.2019.00355","volume":"7","author":"TV Denisenko","year":"2019","unstructured":"Denisenko TV, Gorbunova AS, Zhivotovsky B (2019) Mitochondrial involvement in migration, invasion and metastasis. Front Cell Dev Biol 7:355. https:\/\/doi.org\/10.3389\/fcell.2019.00355","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"2908_CR41","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jtho.2023.07.016","volume":"18","author":"C Arolt","year":"2023","unstructured":"Arolt C, Dugan M, Wild R et al (2023) KEAP1\/NFE2L2 pathway signature outperforms KEAP1\/NFE2L2 mutation status and reveals alternative pathway-activating mutations in NSCLC. J Thorac Oncol 18(11):1550\u20131567. https:\/\/doi.org\/10.1016\/j.jtho.2023.07.016","journal-title":"J Thorac Oncol"},{"key":"2908_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.lungcan.2021.07.006","volume":"159","author":"WCM Dempke","year":"2021","unstructured":"Dempke WCM, Reck M (2021) KEAP1\/NRF2 (NFE2L2) mutations in NSCLC - fuel for a superresistant phenotype? Lung Cancer 159:10\u201317. https:\/\/doi.org\/10.1016\/j.lungcan.2021.07.006","journal-title":"Lung Cancer"},{"issue":"5","key":"2908_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300659","volume":"8","author":"Y Cao","year":"2024","unstructured":"Cao Y, Fu A, Liu C (2024) Exploring the NRF2-TP53 signaling network through machine learning and pan-cancer analysis: identifying potential targets for cancer prognosis related to oxidative stress. Adv Biol (Weinh) 8(5):e2300659. https:\/\/doi.org\/10.1002\/adbi.202300659","journal-title":"Adv Biol (Weinh)"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02908-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02908-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:02:43Z","timestamp":1764021763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02908-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02908-w","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Keio University Hospital Institutional Ethics Committee (approval numbers: 20200046, 20180015) and was performed in accordance with the Declaration of Helsinki and Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan. Consent for participation was obtained using an opt-out form available on the website.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}